biotech thread - monday 8th october , page-15

  1. 5,891 Posts.
    Craikey - NOW is the time to look at ADO

    Low cash burn with the last deal (EBio/Affymetrix) in place enough to take the company cash flow positive with some MASSIVE deals with global majors to unfold all over the next 6 months.

    The technology alone would have a takeover price of at least $200m or 25 cents per share in my opinion

    My target range is .50 - 1.00 +

    This is a long term hold that will pay dividends

    What will be intereresting to watch as news comes out is a lot are sitting on the sidelines watching this one and technically when it breaks .105 every man and his dog will jump in to it and to magnify this technical level - The CEO has presented to many instos/funds whose requirements are the magical $100m MCAP level which for ADO is about .125 cents

    I expect this to be 20 cents plus over the coming months


 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.